FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

Share this content:
FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs
FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

THURSDAY, Aug. 27, 2015 (HealthDay News) -- A proposal for identifying lower-cost generic biotech drugs has been released by the U.S. Food and Drug Administration.

Many newer biotech drugs cost more than $10,000 a year and this class of drugs accounts for nearly 30 percent of all drug spending in the country, according to the Associated Press. Earlier this year, the agency approved the first biosimilar drug, the term for generic biotech drugs.

Under the FDA proposal, all biotech drugs would carry a four-letter code to help doctors and pharmacists distinguish brand name and generic versions, the AP reported. Public comments on the proposal will be accepted for 60 days before the FDA moves to finalize the rule.

Generic biotech drugs have been available in Europe since 2006 and about 20 have been approved there, the AP reported.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Dermatography Helps Lessen Appearance of Surgical Scars

Dermatography Helps Lessen Appearance of Surgical Scars

Pigments can restore more natural skin appearance that patients are happy with

Drug-Resistant Bacteria Live in America's Water Systems

Drug-Resistant Bacteria Live in America's Water Systems

Bacteria found in plumbing may sicken thousands each year

Deep Brain Stimulation May Improve TBI Symptoms

Deep Brain Stimulation May Improve TBI Symptoms

Deep brain stimulation appears to boost function and quality of life

is free, fast, and customized just for you!

Already a member?

Sign In Now »